We subsequently constructed the Kaplan–Meier curve of breast cancer patients using the GEO database (n = 2032, best cut–off), which showed that a lower CLDN6 level was associated with a worse relapse–free survival (RFS) (Figure 1D). Here, CLDN6 is linked to breast carcinoma.